Back to Search Start Over

Visceral leishmaniasis infection in a fingolimod-treated multiple sclerosis patient.

Authors :
Artemiadis, AK
Nikolaou, G
Kolokythopoulos, D
Tegos, N
Terentiou, A
Triantafyllou, N
Papanastasiou, I
Source :
Multiple Sclerosis Journal; May2015, Vol. 21 Issue 6, p795-796, 2p
Publication Year :
2015

Abstract

A letter to the editor is presented which discusses the two case studies regarding the two patients who was diagnosed with visceral leishmaniasis infection during the treatment of multiple sclerosis (MS) using oral immunomodulatory drug fingolimod.

Details

Language :
English
ISSN :
13524585
Volume :
21
Issue :
6
Database :
Complementary Index
Journal :
Multiple Sclerosis Journal
Publication Type :
Academic Journal
Accession number :
102576187
Full Text :
https://doi.org/10.1177/1352458514555788